tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TipRanksTop Financial ExpertsInsidersIan Read

Ian Read Insider Profile

4 Followers
Ian Read, EC, Director at Pfizer, holds 14.50K shares in Viatris (Ticker: VTRS), holds 48.80K shares in DXC Technology (Ticker: DXC), holds 1.12M shares in Pfizer (Ticker: PFE).
See the Hottest Stocks Based on Insider Trading >
tipranks
Ian Read

Ian Read
Pfizer (PFE)
EC, Director

Ranked #63,145 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-11.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$31M
95.47%
3.62%
0.61%
0.30%
A breakdown of Ian Read's holdings
See the Top Stocks by Insiders

Insider Roles

Pfizer
(PFE)
EC, Director
DXC Technology
(DXC)
Director
Viatris
(VTRS)
Director
Kimberly Clark
(KMB)
Director
Roles that Ian Read holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Pfizer
(PFE)
Rating:Informative Sell
Date:May 11, 2016 - May 11, 2017
Return:-3.40%
The most profitable trade made by Ian Read
See the Latest Stocks Traded by Insiders

Ian Read's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PFE
Pfizer
Mar 06, 2019
EC, Director
Uninformative Sell
22.88M
$29.35M
DXC
DXC Technology
Aug 24, 2021
Director
Uninformative Buy
―
$1.11M
VTRS
Viatris
Mar 23, 2022
Director
Uninformative Buy
1.79K
$187.45K
KMB
Kimberly Clark
―
Director
―
$92.50K
List of latest transactions for each holding click on a transaction to see Ian Read's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Ian Read insider profile FAQ

What is the percentage of profitable transactions made by Ian Read?
The percentage of profitable transactions made by Ian Read is 0%.
    What is the average return per transaction made by Ian Read?
    The average return per transaction made by Ian Read is -11.20%.
      What stocks does Ian Read hold?
      Ian Read holds: PFE, DXC, VTRS, KMB stocks.
        What was Ian Read’s latest transaction?
        Ian Read latest transaction was an Uninformative Buy of $1.79K.
          What was Ian Read's most profitable transaction?
          Ian Read’s most profitable transaction was an Informative Sell of PFE stock on May 11, 2016. The return on the trade was -3.40%.
            What is Ian Read's role in Pfizer?
            Ian Read's role in Pfizer is EC, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.